Market Overview

Deutsche Bank Reiterates Buy Rating, $88 PT on Mead Johnson Nutrition

Related MJN
JP Morgan's New Way To Value Food Stocks Can Only Be Described As 'Fascinating'
What China Means For Staples Stocks
Mead Johnson Nutrition - China Hurts In The Short Run, Provides Long-Term Opportunities (Seeking Alpha)

In a report published Wednesday, Deutsche Bank reiterated its Buy rating and $88.00 price target on Mead Johnson Nutrition (NYSE: MJN).

Deutsche Bank noted, “Although the stock has been under pressure given concerns around China growth, we continue to view the LT outlook as compelling. Mead enjoys a modest premium valuation vs. global CPG peers. But we see this as justified given leading global share in a rational category, excellent margins, and investments that should yield high returns.”

Mead Johnson Nutrition closed on Tuesday at $73.59.

Latest Ratings for MJN

Oct 2015NomuraUpgradesNeutralBuy
Jul 2015BMO CapitalMaintainsMarket Perform
Jul 2015Deutsche BankMaintainsHold

View More Analyst Ratings for MJN
View the Latest Analyst Ratings

Posted-In: Deutsche BankAnalyst Color Reiteration Analyst Ratings


Related Articles (MJN)

View Comments and Join the Discussion!

Get Benzinga's Newsletters